680
Participants
Start Date
September 30, 2016
Primary Completion Date
April 30, 2020
Study Completion Date
July 31, 2020
Bladder EpiCheck Urine Test
The Bladder EpiCheck test is an in vitro diagnostic device for the detection of DNA methylation patterns in urine that are associated with bladder cancer. It is intended for use as a noninvasive method for monitoring for tumor recurrence in conjunction with cystoscopy inpatients previously diagnosed with bladder cancer
Cystoscopy and pathology
Routine cystoscopy for bladder cancer recurrence and pathology confirmation for patients with positive cystoscopy
Urological Surgeons of Long Island, Garden City
Chesapeake Urology Research Associates, Baltimore
Duke University Health System, Durham
Vanderbilt University Medical Center, Nashville
Cleveland Clinic, Cleveland
Michigan Institute of Urology, P.C., Troy
Metro Urology, Woodbury
Urology San Antonio, San Antonio
The Urology Center of Colorado, Denver
University Of Washington, Seattle
UHN, Princess Margret Cancer center, Toronto
Lead Sponsor
Nucleix Ltd.
INDUSTRY